84 related articles for article (PubMed ID: 4064248)
1. Polymorphic metabolism of the carcinogen 2-acetylaminofluorene in human liver microsomes.
Minchin RF; McManus ME; Boobis AR; Davies DS; Thorgeirsson SS
Carcinogenesis; 1985 Dec; 6(12):1721-4. PubMed ID: 4064248
[TBL] [Abstract][Full Text] [Related]
2. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of 2-acetylaminofluorene by rat liver microsomes.
Hara E; Kawajiri K; Gotoh O; Tagashira Y
Cancer Res; 1981 Jan; 41(1):253-7. PubMed ID: 6778605
[No Abstract] [Full Text] [Related]
4. Microsomal metabolism of 2-acetylaminofluorene, role in mutagenicity and carcinogenicity.
Roberfroid M; Razzouk C; Agazzi-Léonard E; Batardy-Grégoire M; Poncelet F; Mercier M
Adv Exp Med Biol; 1981; 136 Pt B():921-9. PubMed ID: 7344520
[No Abstract] [Full Text] [Related]
5. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
[TBL] [Abstract][Full Text] [Related]
6. Metabolic processing of 2-acetylaminofluorene by microsomes and six highly purified cytochrome P-450 forms from rabbit liver.
McManus ME; Minchin RF; Sanderson N; Schwartz D; Johnson EF; Thorgeirsson SS
Carcinogenesis; 1984 Dec; 5(12):1717-23. PubMed ID: 6499123
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
Razzouk C; Batardy-Grégoire M; Roberfroid M
Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
[TBL] [Abstract][Full Text] [Related]
8. Metabolic characterization of human liver microsomal cytochromes P-450 involved in the oxidation of debrisoquine, bufuralol and the carcinogen 2-acetylaminofluorene.
McManus ME
Pharmacol Ther; 1987; 33(1):47-53. PubMed ID: 2888142
[No Abstract] [Full Text] [Related]
9. Teratogenicity in vitro of 2-acetylaminofluorene: role of biotransformation in the rat.
Faustman-Watts E; Greenaway JC; Namkung MJ; Fantel AG; Juchau MR
Teratology; 1983 Feb; 27(1):19-28. PubMed ID: 6845215
[No Abstract] [Full Text] [Related]
10. Kinetics of N- and C-hydroxylations of 2-acetylaminofluorene in male Sprague-Dawley rat liver microsomes: implications for carcinogenesis.
McManus ME; Minchin RF; Sanderson N; Wirth PJ; Thorgeirsson SS
Cancer Res; 1983 Aug; 43(8):3720-4. PubMed ID: 6861141
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a microsomal fraction from rat small intestine for metabolic activation of some promutagens.
Walters JM; Combes RD
Carcinogenesis; 1985 Oct; 6(10):1415-20. PubMed ID: 4042271
[TBL] [Abstract][Full Text] [Related]
12. Catalysis of divergent pathways of 2-acetylaminofluorene metabolism by multiple forms of cytochrome P-450.
Johnson EF; Levitt DS; Muller-Eberhard U; Thorgeirsson SS
Cancer Res; 1980 Dec; 40(12):4456-9. PubMed ID: 7438078
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 2-acetylaminofluorene in cultured human lymphocytes.
McManus ME; Trainor KJ; Morley AA; Burgess W; Stupans I; Birkett DJ
Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):409-18. PubMed ID: 3575877
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
Goldstein JA; Weaver R; Sundheimer DW
Cancer Res; 1984 Sep; 44(9):3768-71. PubMed ID: 6744296
[TBL] [Abstract][Full Text] [Related]
15. Characterization of drug-metabolizing systems in hyperplastic nodules from the livers of rats receiving 2-acetylaminofluorene in their diet.
Aström A; DePierre JW; Eriksson L
Carcinogenesis; 1983; 4(5):577-81. PubMed ID: 6850990
[TBL] [Abstract][Full Text] [Related]
16. In vitro metabolism and activation of carcinogenic aromatic amines by subcellular fractions of human liver.
Dybing E; von Bahr C; Aune T; Glaumann H; Levitt DS; Thorgeirsson SS
Cancer Res; 1979 Oct; 39(10):4206-11. PubMed ID: 476655
[No Abstract] [Full Text] [Related]
17. 2-Acetylaminofluorene metabolism in rat liver microsomes: formation of 9-hydroxy-2-acetylaminofluorene and effect of hepatic enzyme modifiers.
Son OS; Fowble JW; Miller DD; Feller DR
Toxicol Appl Pharmacol; 1979 Nov; 51(2):367-77. PubMed ID: 43607
[No Abstract] [Full Text] [Related]
18. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
[TBL] [Abstract][Full Text] [Related]
19. Inter-individual variation in the mutagenic activation of 2-acetylaminofluorene by human liver in relation to animal metabolic models.
Smith AJ; Chipman JK
Mutagenesis; 1988 Jul; 3(4):323-8. PubMed ID: 3062320
[TBL] [Abstract][Full Text] [Related]
20. Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation.
Meier PJ; Mueller HK; Dick B; Meyer UA
Gastroenterology; 1983 Sep; 85(3):682-92. PubMed ID: 6603386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
